Congratulations to Peter Carlson, graduate student in the Sondel Laboratory, on funding of his Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (F30) for MD/PhD and Other Dual Degrees from the National Institutes of Health, National Cancer Institute (NIH-NCI). This 3-year, fellowship, in the amount of $107,143, is under the sponsorship of Paul Sondel, MD, PhD, and co-Sponsorhip of Zachary Morris, MD, PhD (Human Oncology). The purpose of the F30 program is to enhance the integrated research and clinical training of promising predoctoral students who are matriculated in a combined MD/PhD or other dual-doctoral degree training program, and who intend careers as physician-scientists or other clinician-scientists. Peter's project, "Molecular targeted radiotherapy to overcome resistance to in situ cancer vaccination," will build on the expertise of the Sondel and Morris labs to probe the mechanism of concomitant immune tolerance (CIT). The grant will provide insight into how these murine cancers avoid and escape immune destruction, how immune escape can be overcome in these settings, and will be used to establish a novel combination immunotherapy that could be readily translated into clinical testing.